Загрузка...
The MAPK Pathway-Based Drug Therapeutic Targets in Pituitary Adenomas
Mitogen-activated protein kinases (MAPKs) include ERK, p38, and JNK MAPK subfamilies, which are crucial regulators of cellular physiology, cell pathology, and many diseases including cancers. For the MAPK signaling system in pituitary adenomas (PAs), the activation of ERK signaling is generally thou...
Сохранить в:
| Опубликовано в: : | Front Endocrinol (Lausanne) |
|---|---|
| Главные авторы: | , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Frontiers Media S.A.
2019
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6558377/ https://ncbi.nlm.nih.gov/pubmed/31231308 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fendo.2019.00330 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|